Chapter III. Technology Transition
Army Science and Technology Master Plan (ASTMP 1997)


3. Combat Health Support Modernization Strategy

Modernization efforts focus on the development of medical materiel, through a DoD drug and vaccine program, for countering potential mission aborting infectious diseases as well as chemical and biological warfare agents. Such drugs and vaccines are not normally developed by the U.S. pharmaceutical industry. Additional capabilities of the medical program include technologies supporting far-forward casualty treatment; individual sustainment (self aid devices and techniques) to reduce the severity of ballistic, thermal, and directed energy injuries; topical skin protectants; blood substitutes; and miniature and filmless x-rays. The modernization strategy also addresses nutritional and physiological approaches to minimize the impact of military operational stresses which degrade the capabilities of, or render inoperable, the human component of combat systems.